TOP2A (17q21) / SE 17

The Topoisomerase2A enzyme, which is vital for the cell because of its role in cell replication and repair, catalyzes the relaxation of supercoiled DNA molecules to create a reversible double-strand DNA break.

This enzyme is also the target of a number of cytotoxic agents, namely TOP2A inhibitors (anthracyclines, etoposide, teniposide).

The presence of both TOP2A amplification and deletion in advanced cancer are associated with decreased survival, and occur frequently and concurrently with Her2 gene amplification.

The Dual-Color Probe is optimized to detect amplifications (copy-numbers) or deletions of the TOP2A gene region at the 17q21. In order to expand the utility of the FISH assay, the TOP2A (17q21) / Her2/neu (17q12) / SE17 probe is designed as a triple-color assay to detect amplification at 17q12 and amplifications or deletions at 17q21.

Cat.# KBI-10724 Top2A (17q21) / SE 17 

TOP2A (17q21) / SE 17 probe hybridized to breast tissue (2R2G).

Literature:
Järvinen et al, 1999, Genes, Chromosomes and Cancer 26; 142-150
Järvinen et al, 2000, Am. J. Pathology 156; 639-647

Back

You selected International. The content of this website is specific for this region. The information provided on this website may not be approved in North America. If you are a resident of a country other than those to which the site is directed, please cancel this request and contact your local Kreatech Representative to obtain the appropriate product information for your country of residence.

You are going to the International site.

Do you want to continue?

You selected North America as your location. The content of this website is specific for this region. The information provided on this website may not be approved in the Rest of the World. If you are a resident of a country other than those to which the site is directed, please cancel this request and contact your local Kreatech Representative to obtain the appropriate product information for your country of residence.

You are going to the North America site.

Do you want to continue?